简报:狼疮性肾炎中的肾小管间质损伤:与肾小管间质炎症和肾脏瘢痕形成相关因素的比较
该研究纳入2005至2017年间经肾活检确诊为狼疮性肾炎的203例系统性红斑狼疮患者,比较与肾小管间质炎症(TII)及肾小管间质瘢痕形成(IF/TA)相关的因素。多变量逻辑回归显示,羟氯喹使用与中重度TII风险显著降低相关(OR 0.27,95%CI 0.10-0.70,P=0.008);增殖性狼疮性肾炎和活检时eGFR<60 ml/min/1.73 m²与TII及IF/TA均相关。
要点
- 203例狼疮性肾炎患者中,41例(20%)有中重度TII,45例(22%)有中重度IF/TA,21例(10%)两者并存。
- 羟氯喹使用与中重度TII风险显著降低相关(OR 0.27,95%CI 0.10-0.70,P=0.008)。
- 增殖性狼疮性肾炎、活检时eGFR<60 ml/min/1.73 m²与中重度TII及中重度IF/TA均相关。
核心结论
- 羟氯喹使用与狼疮性肾炎患者肾小管间质炎症显著减少相关,而TII的存在、增殖性狼疮性肾炎和低eGFR是肾小管间质瘢痕形成的主要决定因素。
研究设计与样本
- 研究纳入2005至2017年间肾活检结果符合狼疮性肾炎的系统性红斑狼疮患者203例,从医疗记录收集临床数据,采用多变量逻辑回归模型评估与中重度TII及中重度IF/TA(对比无/轻度)相关的因素。
主要发现
- 203例狼疮性肾炎患者中,41例(20%)有中重度TII,45例(22%)有中重度IF/TA,21例(10%)两者并存。
- 多变量逻辑回归显示,中重度TII与较短病程、非裔美国人种族、增殖性狼疮性肾炎及活检时eGFR<60 ml/min/1.73 m²相关。
- 羟氯喹使用与中重度TII风险显著降低相关(OR 0.27,95%CI 0.10-0.70,P=0.008)。
- 与中重度IF/TA相关的因素包括增殖性狼疮性肾炎、活检时eGFR<60 ml/min/1.73 m²、中重度TII的存在及较大年龄。
- 常规可用的血清学标志物(包括抗双链DNA抗体、抗Ro/La抗体和低补体)均与肾小管间质损伤无关。
关键数值与推荐
- 中重度TII定义为20%的患者(41/203),中重度IF/TA定义为22%的患者(45/203),两者并存为10%(21/203)。
- 羟氯喹使用与中重度TII的OR为0.27(95%CI 0.10-0.70,P=0.008)。
- 增殖性狼疮性肾炎和活检时eGFR<60 ml/min/1.73 m²与中重度TII及中重度IF/TA均相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize and compare the factors associated with tubulointerstitial inflammation (TII) and tubulointerstitial scarring, defined as interstitial fibrosis and/or tubular atrophy (IF/TA), in patients with lupus nephritis (LN). METHODS: We identified systemic lupus erythematosus patients who had renal biopsy results consistent with LN between 2005 and 2017. Clinical data were collected from medical records. Multivariable logistic regression models were fitted to assess factors associated with TII and with IF/TA (moderate-to-severe versus none/mild). RESULTS: Of 203 LN patients included, 41 (20%) had moderate-to-severe TII, 45 (22%) had moderate-to-severe IF/TA, and 21 (10%) had both. Multivariable logistic regression models showed that moderate-to-severe TII was associated with a shorter disease duration, African American race, proliferative LN, and an estimated glomerular filtration rate (eGFR) of <60 ml/minute/1.73 m2 at the time of biopsy. Hydroxychloroquine use was associated with significantly lower odds of moderate-to-severe TII (odds ratio 0.27 [95% confidence interval 0.10-0.70], P = 0.008). Similar to TII, factors associated with moderate-to-severe IF/TA included proliferative LN and eGFR <60 ml/minute/1.73 m2 at the time of biopsy. In addition, the presence of moderate-to-severe TII and older age was associated with moderate-to-severe IF/TA. None of the routinely available serologic markers-including anti-double-stranded DNA antibodies, anti-Ro/La antibodies, and low complement-were associated with tubulointerstitial damage. CONCLUSION: The use of hydroxychloroquine was strongly associated with less inflammation, while the presence of TII, proliferative LN, and low eGFR were major determinants of tubulointerstitial scarring. Identifying modifiable factors is critical for the development of better preventive and therapeutic strategies with the goal of improving survival in patients with lupus-related kidney disease.
引用
- Londoño Jimenez A, Mowrey WB, Putterman C, et al. Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring. Arthritis Rheumatol. 2018. PMID: 29851285. doi:10.1002/art.40575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。